ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 55,210 Value ($000) $850 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 51,683 Value ($000) $1,058 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 83,054 Value ($000) $1,666 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 35,898 Value ($000) $706 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 43,714 Value ($000) $984 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 26,168 Value ($000) $668 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 23,224 Value ($000) $543 Avg Close $21.05 Range $15.96 - $26.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	55,210	$850	$19.92	$15.14 - $24.64
Q3 2025	51,683	$1,058	$20.16	$17.43 - $24.38
Q2 2025	83,054	$1,666	$18.93	$13.30 - $24.11
Q1 2025	35,898	$706	$21.52	$18.67 - $25.37
Q4 2024	43,714	$984	$25.92	$21.43 - $30.03
Q3 2024	26,168	$668	$23.16	$20.63 - $27.67
Q2 2024	23,224	$543	$21.05	$15.96 - $26.00